$124.40
▼ -0.3% Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project
Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript
Twist Bioscience (TWST) Is Up 26.3% After Capital Raise And Guidance Hike Amid Legal Settlement Talks - Has The Bull Case Changed?
Overview
52-week range
$23
$155
77% of range
Avg surprise (last 3)
-6.6%
Avg reaction (last 2)
-7.7%
0% positive
Latest IV / EM
70%
EM ±11.0% · $125 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.56 | — | — | — | — | financials |
| Mon May 4, 2026 | Mar/2026 | $-0.62 | $-0.54 | -14.8% | +6.1% | -7.0% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.50 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $-0.47 | $-0.54 | +13.0% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $-0.66 | $-0.56 | -17.9% | — | -8.4% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.53 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.47 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.79 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.01 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.04 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $118M | $111M | $104M | — | $96M | $93M | $89M | — |
| Cost of revenue | $56M | $54M | $50M | — | $45M | $47M | $46M | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-36M | $-46M | $-33M | — | $-30M | $-42M | $-35M | — |
| Net income | $-35M | $-44M | $-31M | — | $20M | $-39M | $-32M | — |
| EPS (diluted) | $-0.56 | $-0.71 | $-0.50 | — | $0.33 | $-0.66 | $-0.53 | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $117M | $123M | $149M | $183M | $201M | $210M | $221M | $226M |
| Inventory | $35M | $34M | $33M | $28M | $26M | $21M | $24M | $24M |
| Total current assets | $321M | $323M | $304M | $333M | $340M | $338M | $345M | $347M |
| Total assets | $672M | $676M | $638M | $642M | $644M | $596M | $609M | $614M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $227M | $221M | $182M | $169M | $165M | $156M | $153M | $142M |
| Total equity | $446M | $455M | $456M | $473M | $478M | $440M | $456M | $473M |